M-Pap

Description

No description information is available for the drug.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains associated with various conditions, including headache, muscular aches, backache, arthritis, the common cold, toothache, and menstrual cramps. Additionally, it is indicated for the reduction of fever.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children 12 years of age and older are advised to take 2 teaspoonfuls (10 mL) every 6 hours as needed. The maximum allowable dosage should not exceed 8 teaspoonfuls (40 mL) within a 24-hour period.

For children under 12 years of age, administration should occur only under the direct guidance of a licensed healthcare professional, such as a doctor or pharmacist. It is essential to follow the specific recommendations provided by the healthcare provider regarding the appropriate dosage and frequency for this age group.

Contraindications

Use of this product is contraindicated in the following situations:

Patients should not use this product in conjunction with any other medication containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. If there is uncertainty regarding the presence of acetaminophen in other medications, consultation with a healthcare professional is advised.

This product is contraindicated in individuals with a known allergy to acetaminophen or any of the inactive ingredients contained within the formulation.

Additionally, the product should not be used for pain relief for more than 10 days or for fever for more than 3 days unless directed by a healthcare provider.

Warnings and Precautions

This product contains acetaminophen, which carries specific warnings and precautions that healthcare professionals must consider to ensure safe use.

Liver Warning Severe liver damage may occur if the maximum daily dosage of 8 teaspoonfuls (40 mL) is exceeded within a 24-hour period. Additionally, the risk of liver damage increases when acetaminophen is taken in conjunction with other medications containing acetaminophen or when consumed with three or more alcoholic drinks daily while using this product.

Allergy Alert Acetaminophen may lead to severe skin reactions. Symptoms indicative of such reactions include skin reddening, blisters, and rash. Should any of these symptoms manifest, it is imperative to discontinue use immediately and seek medical assistance.

General Precautions Healthcare professionals should advise patients to consult a doctor prior to use if they have any underlying health conditions, particularly liver disease. Furthermore, it is essential to inquire about other medications the patient may be taking, including anticoagulants such as warfarin, to avoid potential interactions.

Emergency Medical Help Instructions In the event of an overdose, immediate medical attention is crucial. Patients or caregivers should contact a Poison Control Center or seek emergency medical help without delay, even if no signs or symptoms are apparent.

Stop Taking and Call Your Doctor Instructions Patients should be instructed to discontinue use and consult a doctor if they experience new symptoms such as rash, hives, itching, or hoarseness; if redness or swelling occurs; if pain worsens or persists beyond 10 days; if fever intensifies or lasts more than 3 days; or if symptoms do not improve. These may indicate a serious condition requiring further evaluation.

Side Effects

Patients using this product should be aware of potential adverse reactions, particularly those related to liver health and allergic responses.

Severe liver damage may occur if patients exceed the maximum daily dosage of 8 teaspoonfuls (40 mL) within a 24-hour period, take this product in conjunction with other medications containing acetaminophen, or consume three or more alcoholic drinks daily while using this product.

Additionally, acetaminophen may lead to severe skin reactions, which can manifest as skin reddening, blisters, or rash. In the event of a skin reaction, patients are advised to discontinue use immediately and seek medical assistance.

Patients should also be vigilant for new symptoms such as rash, hives, itching, or hoarseness, as well as any redness or swelling. If pain persists or worsens beyond 10 days, or if fever intensifies or lasts longer than 3 days, it is crucial to consult a healthcare professional. These symptoms may indicate a serious underlying condition, necessitating prompt medical evaluation.

Drug Interactions

Acetaminophen has been shown to enhance the anticoagulant effects of warfarin, which may result in an elevated risk of bleeding. It is recommended that the International Normalized Ratio (INR) be monitored closely in patients who are receiving both acetaminophen and warfarin concurrently to ensure safe therapeutic levels and to mitigate the risk of adverse effects.

No additional drug interactions or interactions with laboratory tests have been identified.

Packaging & NDC

Below are the non-prescription pack sizes of M-Pap (acetaminophen). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients under 12 years of age should use this medication only under the direct guidance of a licensed healthcare professional, such as a doctor or pharmacist.

For adolescents aged 12 years and older, the recommended dosage is 2 teaspoonfuls (10 mL) every 6 hours, with a maximum limit of 8 teaspoonfuls (40 mL) within a 24-hour period.

Geriatric Use

Elderly patients should consult a healthcare provider prior to use, particularly if they have pre-existing health conditions, especially liver disease.

For adults and children aged 12 years and older, the recommended dosage is 2 teaspoonfuls (10 mL) every 6 hours, with a maximum limit of 8 teaspoonfuls (40 mL) within a 24-hour period.

For children under 12 years of age, administration should occur only under the direct guidance of a licensed healthcare professional, such as a doctor or pharmacist.

It is essential for healthcare providers to monitor geriatric patients closely for any adverse effects or complications, particularly in those with underlying health issues. Adjustments to dosage may be necessary based on individual patient health status and response to treatment.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have no specific information regarding dosage adjustments, special monitoring, or safety considerations provided in the drug insert. Therefore, healthcare professionals should exercise caution when prescribing this medication to individuals with reduced kidney function, as the lack of data necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients, although specific recommendations are not outlined.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, as it contains acetaminophen, which is associated with the risk of severe liver damage. It is critical for patients to adhere to the following guidelines to minimize the risk of hepatotoxicity.

The maximum recommended daily dosage of this product is 8 teaspoonfuls (40 mL). Patients with compromised liver function should not exceed this dosage, as doing so may significantly increase the risk of liver damage. Additionally, patients should avoid concomitant use of other medications containing acetaminophen, as this can further elevate the risk of hepatotoxicity.

Patients with hepatic impairment are also advised to limit alcohol consumption. Specifically, the intake of 3 or more alcoholic drinks per day while using this product may exacerbate the risk of liver damage.

Before initiating treatment, patients with a history of liver disease or other health issues should consult a healthcare professional to assess the appropriateness of this product for their condition. Regular monitoring of liver function may be warranted in these patients to ensure safety and efficacy during treatment.

Overdosage

In the event of an overdose, it is imperative to seek immediate medical assistance or contact a Poison Control Center without delay. Prompt medical attention is critical, even in the absence of noticeable signs or symptoms. Healthcare professionals should be aware that early intervention can significantly impact patient outcomes in cases of overdosage.

It is essential to monitor the patient closely for any potential symptoms that may arise, as these can vary depending on the substance involved. Appropriate management procedures should be initiated based on the specific circumstances of the overdose, including supportive care and symptomatic treatment as necessary.

Healthcare providers are encouraged to remain vigilant and proactive in addressing any overdose situations to ensure the safety and well-being of the patient.

Nonclinical Toxicology

There is currently no available information regarding teratogenic or non-teratogenic effects associated with the compound. Additionally, no data has been provided concerning nonclinical toxicology, including animal pharmacology and toxicology.

Postmarketing Experience

Serious side effects associated with the use of this product may be reported through the designated contact number. Reports received voluntarily or through surveillance programs contribute to the ongoing assessment of the product's safety profile.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center in the event of an overdose, emphasizing that prompt medical attention is critical even if no signs or symptoms are present.

Patients should be informed not to use this medication in conjunction with any other drug containing acetaminophen, whether prescription or nonprescription. If patients are uncertain about the presence of acetaminophen in their medications, they should be encouraged to consult a doctor or pharmacist.

It is important to instruct patients not to use this medication for more than 10 days for pain or more than 3 days for fever unless directed by a healthcare professional. Patients should also be cautioned against using the medication if they have a known allergy to acetaminophen or any of the inactive ingredients in the product.

Healthcare providers should advise patients to discontinue use and consult a doctor if they experience new symptoms such as rash, hives, itching, or hoarseness. Additionally, patients should be instructed to stop use and seek medical advice if they notice redness or swelling, if their pain worsens or persists beyond 10 days, if their fever worsens or lasts more than 3 days, or if their symptoms do not improve, as these may indicate a serious condition.

Patients with underlying health issues, particularly liver disease, should be encouraged to consult a doctor before using this medication. Furthermore, it is advisable for patients to speak with a doctor or pharmacist before use if they are taking other medications, including blood thinners such as warfarin.

Storage and Handling

Dispensed products should be provided in a tight, light-resistant container equipped with a child-resistant cap.

Storage conditions require maintaining a temperature range of 20°C to 25°C (68°F to 77°F), with permissible excursions between 15°C and 30°C (59°F and 86°F).

Additional Clinical Information

Patients aged 12 years and older are advised to take 2 teaspoonfuls (10 mL) every 6 hours, with a maximum of 8 teaspoonfuls (40 mL) within a 24-hour period. For children under 12 years of age, administration should occur only under the direct guidance of a licensed professional, doctor, or pharmacist.

Clinicians should counsel patients to consult a health professional if they are pregnant or breastfeeding before use. In the event of an overdose, it is crucial to seek medical assistance or contact a Poison Control Center immediately, as prompt medical attention is essential, even if no signs or symptoms are present.

Drug Information (PDF)

This file contains official product information for M-Pap, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)